StressMarq Biosciences has developed an extensive range of fibrillar, oligomeric and monomeric protein preparations for use in neurodegenerative disease research including alpha synuclein, beta synuclein, gamma synuclein, tau, amyloid beta, SOD1 and TTR. Our goal is to be the world leader in the development and supply of active, pathology-inducing protein aggregates to assist scientists with disease model development and accelerate neurodegenerative disease drug discovery.

Product Citations

StressMarq’s alpha synuclein, tau, and amyloid beta proteins for neurodegenerative disease research have been cited in many peer-reviewed scientific journals. A comprehensive list of citations for these proteins can be seen here.